期刊文献+

Bevacizumab对兔去上皮瓣微型角膜刀法角膜上皮瓣下原位磨镶术术后角膜上皮下雾状混浊的影响 被引量:1

Inhibition of tropical injected bevacizumab on haze formation after off-flap epipolis laser in situkeratomileusis
下载PDF
导出
摘要 背景角膜屈光手术后角膜上皮下雾状混浊(haze)是影响术后视力改善的主要原因,转化生长因子-β1(TGF-β1)及α-平滑肌肌动蛋白(α-SMA)均参与haze的形成过程。研究发现bevacizumab除可抑制角膜新生血管外,还可加快角膜上皮基底膜形成,但目前bevacizumab对准分子激光角膜屈光手术后haze的产生是否有影响及其机制尚不明确。目的探讨bevacizumab对兔去上皮瓣微型角膜刀法角膜上皮瓣下原位磨镶术(Off-flapEpi—LASIK)术后术区TGF-β1和α-SMA表达的影响。方法24只普通级健康青紫蓝兔均行右眼Off—flap Epi-LASIK手术,术后按随机数字表法随机分为3个组,每组8只。术后10min,2个组兔眼结膜下注射bevacizumab2.5mg(0.1m1),其中bevacizumab重复注射组兔眼于术后4d再次结膜下注射bevacizumab2.5mg(0.1m1)。生理盐水组兔眼术后以同样的方法给予0.1ml生理盐水;另选2只正常兔作为空白对照组。术后每日裂隙灯显微镜下观察haze程度并参照SundarRayde的标准进行评分,分别于术后l周、4周取4只兔眼角膜组织行苏木精-伊红染色和过碘酸希夫染色,观察角膜组织的病理学变化;采用免疫组织化学法检测角膜组织中TGF-β1、α-SMA的表达。结果术后3个组兔眼角膜上皮均于术后4~5d完全愈合。术后1周、4周bevacizumab单次注射组和bevacizumab重复注射组兔眼haze积分值均明显低于生理盐水组,差异均有统计学意义(P〈0.05),但bevacizumab单次注射组和bevacizumab重复注射组间差异均无统计学意义(P〉O.05)。术后4周,角膜组织病理学检查显示bevacizumab单次注射组和bevacizumab重复注射组角膜纤维化反应少,角膜创伤愈合比生理盐水组快。术后1周bevacizumab单次注射组和bevacizumab重复注射组角膜基质层TGF-β1的表达量分别为(49.8±2.1)PU和(38.6±4.4)Pu,4周时分别为(37.7±4.8)Pu和(28.3±3.5)PU,各时间点间TGF-β1的表达量均明显低于生理盐水组的(65.1±5.3)Pu和(51.6±2.2)Pu,差异均有统计学意义(P〈0.05)。术后l周bevacizumab单次注射组和bevacizumab重复注射组角膜基质层α-SMA的表达量分别为(67.2±10.0)PU和(32.7±3.1)PU,4周时分别为(34.2±5.7)PU和(22.8-4-3.O)PU,各时间点间α-SMA的表达量均明显低于生理盐水组的(87.8±7.7)Pu和(59.4±5.6)PU,差异均有统计学意义(P〈0.05)。各时间点间bevacizumab重复注射组角膜基质中TGF-β1和α-SMA的表达量均明显低于bevacizumab单次注射组,差异有统计学意义(P〈O.01)。过碘酸希夫染色表明,术后早期bevacizumab单次注射组和bevacizumab重复注射组角膜基底膜比生理盐水组连续和完整。结论Bevacizumab结膜下注射能下调Off-flap Epi-LASIK术后兔眼早期角膜中TGF-β1和α-SMA的表达水平,减少haze的形成。 Background Haze formation is a key factor of vision reduce following corneal refractive surgery. Transforming growth factor-β1 (TGF-β1) and s-smooth muscle actin (α-SMA) are documented to participate in haze formation. Laboratory study showed that bevacizumab can not only inhibit corneal neovascularization,but also promote the healing of corneal epithelial basement membrane. However, the impact of bevacizumab on corneal healing after Off-flap epipolis laser in situkeratomileusis ( Off-flap Epi-LASIK) is unclear. Objective The present study was to investigate the inhibition effect of bevacizumab on corneal haze after off-flap Epi-LASIK and its active mechanism. Methods Off-flap Epi-LASIK was performed in 24 adult pigmented rabbits and these rabbits were randomized into three groups. Bevacizumab of 0. 1 ml (2.5 rag) was subconjunctivally injected 10 minutes after surgery in 16 rabbits and the same amount of bevacizumab was repeatedly injected 4 days after the initial injection in 8 eyes of 16 eyes. In addition, equivalent amount of normal saline solution was used in the same way in the other 8 rabbits. Another 2 health rabbits were used as the blank controls. Operative eyes were examined by slit lamp biomicroscope daily after surgery and haze was scored based on SundarRayde criteria. Corneas were obtained 4 weeks after operation for hematoxylin & eosin and periodic acid Schiff staining. Expressions of TGF-β1 and α-SMA in corneal tissue were detected by immunochemistry. Results Corneal epithelium healed completely in all eyes 4-5 days after operation. The haze scores were lower in the bevacizumab single injection group and repeat injection group than those in the normal saline solution group (P〈0.05) in 1 week and 4 weeks after operation. However,no significant difference was seen in the haze scores between the bevacizumab single injection group and repeat injection group (P 〉 0.05 ). The hostopathological examination showed that the fibrosis response of cornea tissue was slight in the bevacizumab single injection group and repeat injection group comparison with the normal saline solution group. At 1 week after operation, the expression levels of TGF-131 were (49.8 ±2. l ) PU and (38.6±4.4 ) PU in the bevacizumab single injection group and repeat injection group, and those of 4 weeks were ( 37.7 ±4.8 ) PU and ( 28.3 ± 3.5 ) PU, indicating significant decrease in the TGF-β1 expression compared with (65.1±5.3) PU and (51.6±2.2) PU of the normal saline solution group in both 1 week and 4 weeks (P〈0. 01 ). The expression levels of α-SMA in corneas were (67.2± 10.0) PU and (32.7±3. 1) PU at 1 week,and (34. 2±5.7) PU and (22.8±3.0) PU at 4 weeks after operation in the bevacizumab single injection group and repeat injection group,which were significantly lower than (87.8±7.7) PU and (59.4±5.6) PU in the normal saline solution group in both 1 week and 4 weeks (P〈0.05). Meanwhile,the expression levels of TGF-β1 and et-SMA were declined in the bevacizumab repeat injection group compared with single injection group (P〈O. 01 ). Periodic acid Schiff staining exhibited that the basement membrane of cornea was intact and continued in bevacizumab injection group. But corneal basement membrane was discontinuous in the normal saline solution group. Conclusions Subconjunctival injection of bevacizumab downregulates the expressions of TGF-β1 and α-SMA in cornea after Off-flap Epi-LASIK and thus prevents haze formation.
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2013年第6期529-534,共6页 Chinese Journal Of Experimental Ophthalmology
关键词 去上皮瓣微型角膜刀法角膜上皮瓣下原位磨镶术 BEVACIZUMAB 雾状混浊 基底膜 转化 生长因子-β1 α-平滑肌肌动蛋白 Off-flap epipolis laser in situkeratomileusis Bevacizumab Haze Basement membrane Transforming grown facter-β1 α-Smooth muscle actin
  • 相关文献

参考文献10

  • 1Pallikaris IG, Katsanevaki V J, Kalyvianaki MI, et al. Advances in subepithelial excimer refractive surgery techniques: Epi-LASIK [ J]. Curr Opin Ophthamlol,2003,14 : 207-212.
  • 2Feng YF, Chen SH, Stojanovic A, et al. Comparison of clinical outcomes between ' on-flap' and ' off-flap' epi-LASIK for myopia: a meta- analysis [ J ]. Ophthalmologica, 2012,227 : 45 - 54.
  • 3Lee SH, Leem HS, Jeong SM, et al. Bevacizumab accelerates corneal wound healing by inhibiting TGF-β2 expression in alkali-burned mouse cornea[ J]. BMB Rep ,2009,42:800-805.
  • 4O'Neill EC, Qin Q, van Bergen N J, et al. Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro [ J ]. Invest Ophthalmol Vis Sci ,2010,51 : 6524-6532.
  • 5Choi HY,Lee JH, Lee JE, et al. Effect of bevacizumab on strabismus surgery in rabbits[ J]. Invest Ophthalmol Vis Sci ,2010,51:4585-4588.
  • 6van Bergen T, Vandewalle E,van de Veire S,et al. The role of different VEGF isoforms in scar formation after glaucoma filtration surgery [ J ]. Exp Eye Res,2011,93 : 689-699.
  • 7Stramer BM, Zieske JD, Jung JC, et al. Molecular mechanisms controlling the fibrotlc repair phenotype in cornea: implications for surgical outcomes [ J ]. Invest Ophthalmol Vis Sci ,2003,44 : 4237-4246.
  • 8刘文,陈家祺,刘祖国,陈龙山,黄挺,郑湖玲.正常角膜缘组织中与血管生成相关的生长因子及其受体的表达[J].眼科研究,2002,20(1):15-18. 被引量:4
  • 9陈家祺,刘文,刘祖国,陈龙山,黄挺,郑湖玲.血管内皮生长因子及其受体在病变角膜的表达和临床意义的探讨[J].眼科学报,2002,18(4):203-207. 被引量:10
  • 10Li Z ,van Bergen T,van de Veire S ,et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery [ J ]. Invest Ophthalmol Vis Sci ,2009,50 : 5217-5225.

二级参考文献29

  • 1[1]Pasquale LR,Dorman-Pease MED,Lutty GA,et al.Immunolocalization of TGF-β1,TGF-β2 and TGF-β3 in the anterior segment of the human eye.Invest Ophthalmol Vis Sci,1993,34∶23
  • 2[2]Li DQ,Tseng SCG.Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface.J Cell Physiol,1995,163∶61
  • 3[3]Li DQ,Tseng SCG.Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor, transforming growth factor-α,platelet-derived growth factor B,and interleukin-1β.Invest Ophthalmol Vis Sci,1996,37∶2068
  • 4[4]van Setten GB.Vascular endothelial growth factor (VEGF) in normal human corneal epithelium:detection and physiological importance.Acta Ophthalmol Scand,1997,75∶649
  • 5[5]Imanishi J,Kamiyama K,Iguchi I,et al.Growth factors:Importance in wound healing and maintenance of transparency of the cornea.Prog Retina Eye Res,2000,29∶113
  • 6[6]Casey R,Li WW.Factors controlling ocular angiogenesis.Am J Ophthalmol,1997,124∶521
  • 7[7]Miller JW.Vascular endothelial growth factor and ocular neovascularization.Am J Ophthalmol,1997,151∶13
  • 8[8]Kendall RL,Thomas KA.Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proc Natl Acad Sci USA,1993,90∶10705
  • 9[9]im I,Ryan AM,Roban R,et al.Constitutive expression of VEGF,VEGFR-1,and VEGFR-2 in normal eye.Invest Ophthalmol Vis Sci,1999,40∶2115
  • 10[10]Zieske JD.Perpetuation of stem cells in the eye.Eye,1994,8∶163

共引文献12

同被引文献3

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部